Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The increasing understanding of hormonal imbalances causing excessive hair growth is leading to several trends in the Hirsutism Treatment Market. One notable trend is the growing demand for hormonal therapies. Hormonal treatments like oral contraceptives and anti-androgen medications have gained popularity since hirsutism is often implicated with increased levels of androgens. Another important trend observed in the Hirsutism Treatment Market is an increase in laser and light-based therapies. Technological improvements have seen lasers or intense pulsed light devices used to damage hair follicles by removing them, thus providing a long-lasting solution for hirsutism, which reduces hair growth and improves looks on affected areas. This reflects more cosmetic/aesthetic-oriented approaches to treating hirsutism.
Another area of focus in the market has been on topical medications. Eflornithine hydrochloride-based topical creams are becoming popular due to their ability to slow down hair growth by inhibiting specific enzymes within hair follicles. Lifestyle interventions have also become crucial in the Hirsutism Treatment Market lately. Medical professionals now understand how weight management, dieting, and physical activities impact hormone balance, thus improving major symptoms of hirsutism. The market is also characterized by advances made in diagnostic tools and screening techniques for detecting hirsutism cases early enough before they become severe. A better diagnosis helps medical practitioners identify what's behind excessive body hair growing more easily, implying a more focused approach to personalized therapy. This reflects the desire to ensure that hirsutism is diagnosed with more precision and that treatment is done appropriately.
Moreover, patient education and advertising campaigns have shaped the Hirsutism Treatment Market greatly. They have played a significant role in increasing awareness among individuals concerning hirsutism, its causes, and available remedies, hence leading to early intervention and better patient outcomes. Collaborations with pharmaceutical firms, research institutions, and healthcare organizations are other significant trends in this market. These partnerships aim to fast-track the development of new treatment options and make hirsutism treatments more accessible. Finally, there is an increased interest in herbal treatment for hirsutism or alternative medicine as people seek natural ways to reduce excessive hair growth. While investigations into these areas continue, it indicates a consumer leaning towards holistic approaches and non-conventional healthcare compositions.
Hirsutism Treatment Market Highlights:
Global Hirsutism Treatment Market Overview
Hirsutism Treatment Market Size was valued at USD 3.55 Billion in 2023. The Global Hirsutism Treatment industry is projected to grow from USD 3.84 Billion in 2024 to USD 7.12 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.35% during the forecast period (2024 - 2032).Hirsutism is a condition of excessive, unwanted, and male-pattern hair growth in women. Hirsutism results in unwanted hair growth on body areas such as face, stomach, back, and chest. About 5% of US women have hirsutism.
Increasing procedures, growing awareness of treatments, increasing personal care expenditure, and technological advancement are major factors for the market growth. Increasing R&D and new product development are also important factors for market growth.
BioSyent Inc. is pleased to announce that they have sent the first shipments of the pharmaceutical product Inofolic® to Canada in August 2023 through their subsidiary, BioSyent pharma inc., Inofolic® is a health product made from myo-inositol and folic acid contained in a particular soft gel that assists women having PCOS. A condition affecting an approximate of about 1.4 million womenii; hormonal imbalance (PCOS) affects various aspects of a woman’s body. Including insulin resistance, difficulty in conceiving, menstrual disorder and skin manifestations like pimples and hirsutism (excessive hair growth), alopecia.
In June 2022, Halozyme Therapeutics, Inc. announced commercial availability of TLANDO™ their oral testosterone replacement therapy drug for treatment of men with primary or hypogonadotropic hypogonadism due to deficiencies or absence of endogenous testosterone The US Food and Drug Administration approved this medication on 28th March.Male hypogonadism means that the body does not produce enough testosterone.
In October 2022, Sensus Healthcare, Inc. displayed their latest portable Sensus Silk hair removal system with blended wavelengths at the Fall Clinical Dermatology Conference held in Las Vegas; this system emits light vertically into the skin which means it maintains laser density over a given area, allowing deep penetration and better distribution of energy as well as making its deposition uniform inside.
October 2022: Endymed Ltd has been granted FDA approval to sell and market Pure Laser which is a new hair removing laser device that can be used on all types of skin sold in the USA. This move enables the company to extend its spectrum of aesthetic treatments for both partners and customers of the Company.
Lumenis introduced Splendor X to the UK market in March 2022. This versatile device is suitable for all Fitzpatrick skin types and addresses men’s and women’s needs alike.
ALLERGAN has segmented its business into US specialized therapeutics, US general medicine, international and others. The goods that are being offered by the company include VANIQA. It is an ointment which contains eflornithine hydrochloride monohydrate (150 mg/g) equivalent to 13.9% w/w anhydrous eflornithine hydrochloride.It is prescribed for excessive facial hair growth in women.
Hirsutism Treatment Market Segment Insights
Hirsutism Treatment Type Insights
Hirsutism treatment market has been segmented on the basis of type which comprises of idiopathic hirsutism, secondary hirsutism, and others.
Hirsutism Treatment Diagnosis Insights
On the basis of diagnosis, the market is segmented into blood tests, imaging tests, physical examination, and others. Blood tests sub-segmented into testosterone level test, DHEA-sulfate test, and others. Imaging test sub-segmented into ultrasound, CT scan, and others. Physical examination sub-segmented into inspection, auscultation, palpation and percussion, and others.
Hirsutism Treatment Insights
On the basis of treatments, the market has been segmented into medications, procedures, and others. Medication is sub-segmented into oral contraceptives, anti-androgens, topical cream, and others. Procedures include electrolysis, laser therapy, and others.
Hirsutism Treatment End-User Insights
On the basis of end user, it is segmented into hospitals and clinics, medical research centers, academic institutes, and others.
Hirsutism Treatment Regional Insights
Considering the global scenario of the market, America is holding the largest market share. The Americas are second largest hirsutism treatment market, especially developed North America region is holding the largest market share not only in America but also in hirsutism treatment market. While UK is believed to be the fastest growing market for hirsutism treatment in European region. Factors like technological advancement, and increasing demand for treatments are leading the growth for this region. Europe is the second largest market for hirsutism. Due to Increasing awareness, rising healthcare expenditure, availability of affordable healthcare facilities, Asia Pacific is fastest growing region in hirsutism market. Middle East and Africa contributes least market share and expected to grow slower than global average growth rate.
The report for Hirsutism treatment Marketof Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions
Key players for Hirsutism treatment market:
- AbbVie Inc. (US)
- Allergan (Republic of Ireland)
- Bayer AG (Germany)
- Bristol-Myers Squibb Company (US)
- Jubilant Cadista (US)
- Pfizer Inc. (US)
- Sun Pharmaceutical Industries Ltd. (India)
Study objectives of hirsutism treatment market:
- To provide detailed analysis of the hirsutism treatment market structure with historical and forecast revenue for the next six years of the various segments and sub-segments.
- To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of hirsutism treatment market
- To provide analysis of the market with respect to various countries in the four main geographies– the Americas, Europe, Asia Pacific, and Middle East & Africa.
- To provide detailed analysis of the market segmented by type, diagnosis, treatment, end user, and its sub-segments.
- To provide a detailed analysis of hirsutism treatment market mainly based on Value Chain Analysis, Porter’s Five Forces, Price Analysis, and Supply Chain Analysis etc.
- To provide a detailed country level analysis of the market with respect to the current market size and future prospects.
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the hirsutism treatment market.
- To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the hirsutism treatment market.
Intended Audience:
- Hirsutism treatment medicines manufacturers
- Hirsutism medicines and treatment providers
- Hospitals and clinics
- Medical Research laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
